Cogent Biosciences: Trio Of Approvals Beckon For Lead Drug - Still Bullish

Group 1 - The article discusses the performance of Cogent Biosciences, Inc. (COGT), highlighting that its shares were rising as the market reacted to recent data [1] - The company is based in Waltham, Massachusetts, and operates within the biotech sector [1] - The author, Edmund Ingham, has extensive experience in biotech consulting and has produced detailed reports on over 1,000 companies [1] Group 2 - The investing group Haggerston BioHealth provides insights for both novice and experienced biotech investors, including catalysts to watch and buy/sell ratings [1] - The group also offers forecasts for product sales and integrated financial statements for major pharmaceutical companies [1]